血氧水平依赖磁共振成像检测肝移植后急性细胞性排斥反应
前瞻性纳入55例高度疑似急性细胞性排斥反应的肝移植受者,治疗前行肝脏血氧水平依赖磁共振成像、血生化和活检,其中19例确诊排斥者治疗后复查磁共振。病理证实27例存在排斥反应,其肝脏R2*值显著低于无排斥者,R2*值检测排斥反应的敏感度和特异度分别为82.1%和89.9%;免疫抑制治疗后R2*值和肝功能显著升高。作者认为血氧水平依赖磁共振技术可能有助于评估肝脏急性细胞性排斥反应并监测治疗反应。
要点
- 肝移植后急性细胞性排斥反应患者肝脏R2*值显著低于无排斥者。
- R2*值检测急性细胞性排斥反应的敏感度82.1%、特异度89.9%。
- 免疫抑制治疗后R2*值和肝功能显著升高。
核心结论
- 无创血氧水平依赖磁共振技术可能有助于评估肝脏急性细胞性排斥反应并监测免疫抑制治疗后的反应。
研究设计与样本
- 前瞻性研究,经当地机构审查委员会批准,纳入55例高度疑似急性细胞性排斥反应的肝移植受者,治疗前均行肝脏血氧水平依赖磁共振成像、血生化检查和活检,其中19例确诊排斥者治疗后接受随访磁共振;在R2*图上于肝实质放置5个感兴趣区估算平均R2*值。
关键影像表现/征象
- 急性细胞性排斥反应患者肝脏R2*值显著低于无排斥患者。
- 免疫抑制治疗后急性细胞性排斥反应患者的R2*值和肝功能显著升高。
诊断标准与关键数值
- R2*值检测急性细胞性排斥反应的敏感度为82.1%,特异度为89.9%。
- 组织病理学结果显示55例中27例存在急性细胞性排斥反应,其中轻度14例、中度11例、重度2例。
临床应用与阅片要点
- 作者认为血氧水平依赖磁共振技术可能有助于评估肝脏急性细胞性排斥反应并监测免疫抑制治疗后的反应。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Acute cellular rejection (ACR) is a major immune occurrence post-liver transplant that can cause abnormal liver function. Blood oxygen level-dependent (BOLD) magnetic resonance imaging (MRI) can be used to evaluate liver disease, but it has not been utilized in the diagnosis of ACR post-liver transplant. Therefore, the purpose of this study is to evaluate the diagnostic performance of BOLD MRI and to monitor treatment response in recipients with ACR.
METHODS: This prospective study was approved by the local institutional review board. Fifty-five recipients with highly suspected ACR were enrolled in this study. Each patient underwent hepatic BOLD MRI, blood biochemistry, and biopsy before treatment. Of 55 patients, 19 recipients with ACR received a follow-up MRI after treatment. After obtaining the R2* maps, five regions-of-interest were placed on liver parenchyma to estimate the mean R2* values for statistical analysis. Receiver operating characteristic curve (ROC) analysis was performed to assess the diagnostic performance of R2* values in detecting patients with ACR.
RESULTS: The histopathologic results showed that 27 recipients had ACR (14 mild, 11 moderate, and 2 severe) and their hepatic R2* values were significantly lower than those of patients without ACR. ROC analysis revealed that the sensitivity and specificity of the R2* values for detection of ACR were 82.1% and 89.9%, respectively. Moreover, the R2* values and liver function in patients with ACR significantly increased after immunosuppressive treatment.
CONCLUSION: The non-invasive BOLD MRI technique may be useful for assessment of hepatic ACR and monitoring of treatment response after immunosuppressive therapy.
KEY POINTS: • Patients with acute cellular rejection post-liver transplant exhibited significantly decreased R2* values in liver parenchyma. • R2* values and liver function were significantly increased after immunosuppressive therapy. • R2* values were constructive indicators in detecting acute cellular rejection due to their high sensitivity and specificity.
引用
- Chiang, Chou, Chuang, et al. Use of blood oxygen level-dependent magnetic resonance imaging to detect acute cellular rejection post-liver transplantation. Eur Radiol. 2022. PMID: 35247088. doi:10.1007/s00330-022-08574-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。